Dasatinib and Leukemia: What PubMed Studies Show

By Insight Swarm Research Team, Medical Advisor: Nikhil Joshi, MD, FRCPC

Dasatinib and Leukemia: What PubMed Studies Show

PubMed is the primary database of biomedical literature maintained by the National Library of Medicine. This page describes what PubMed-indexed research reveals about Dasatinib in the context of Leukemia. This is a research summary — not medical advice. Consult your hematologist or oncologist.

Volume of Available Research

As of 2026, PubMed contains dozens of relevant publications when searching for "Dasatinib" combined with "Leukemia". The current evidence level derived from this literature is: FDA-approved for CML; Mayo Clinic senolytic trials with quercetin; Alzheimer's trial underway

Types of Studies Available

Given the scientific interest in this combination, the published literature includes a range of study types:

  • In vitro (cell culture) studies: Laboratory investigations of Dasatinib effects on Leukemia-relevant cell lines
  • In vivo (animal) studies: Preclinical models examining effects on disease pathways
  • Review articles: Systematic reviews and meta-analyses synthesizing available evidence
  • Clinical studies: Human data from case reports, cohort studies, or clinical trials

How to Search PubMed Yourself

To find the most current and complete literature, use these PubMed search strategies:

  • Basic search: Dasatinib Leukemia
  • Advanced search: (Dasatinib[Title/Abstract]) AND (Leukemia[Title/Abstract])
  • Filter by article type: Select "Clinical Trial" to focus on human studies
  • Sort by: Most Recent to see latest publications

Interpreting PubMed Results

When reviewing PubMed studies for Dasatinib and Leukemia, key considerations include:

  • Study design hierarchy: RCTs > cohort studies > case-control > case reports > animal studies > cell culture
  • Sample size: Small studies (n<50) should be interpreted cautiously
  • Conflict of interest: Check funding sources
  • Replication: Single studies should not change treatment decisions

Medical Disclaimer: This page summarizes published research and is not medical advice. Never start, stop, or change any treatment based on information found online. Always consult qualified healthcare professionals before making treatment decisions.

Get a personalized AI-generated research report at insightswarm.ai.

Frequently Asked Questions

How many PubMed studies exist on Dasatinib for Leukemia?

The exact count changes as new research is published. Search pubmed.ncbi.nlm.nih.gov for 'Dasatinib AND Leukemia' to get the current count. The evidence level from available literature is: FDA-approved for CML; Mayo Clinic senolytic trials with quercetin; Alzheimer's trial underway.

Are there PubMed clinical trial results for Dasatinib in Leukemia?

To find clinical trial publications: go to PubMed, search 'Dasatinib Leukemia', then use the 'Article type' filter to select 'Clinical Trial'. Some clinical data exists for this combination.

Can I access the full text of Dasatinib + Leukemia studies for free?

Many NIH-funded studies are available free via PubMed Central (PMC). For paywalled articles, try: the author's institution page, ResearchGate, or emailing the corresponding author directly. Some patients also access papers through their hospital library or university networks.